Table 2. The relationship between variables and overall and cancer-specific survival in patients with bladder cancer: univariate analysis.
Overall
|
Cancer specific
|
|||
---|---|---|---|---|
Hazard ratio | P-valuea | Hazard ratio | P-valuea | |
Age (⩽65/>65 years) | 0.063 | 0.142 | ||
Sex (male/female) | 0.338 | 0.803 | ||
Stage | ||||
(Superficial/invasive) | 2.82 (1.74–4.57) | <0.001 | 4.96 (2.61–9.41) | <0.001 |
Grade (G1/G2/G3) | 1.48 (1.14–1.92) | 0.004 | 2.17 (1.45–3.23) | <0.001 |
Preoperative C-reactive protein (⩽10/>10 mg l−1) | 2.50 (1.15–5.43) | 0.021 | 3.03 (1.04–8.87) | 0.043 |
Postoperative C-reactive protein (⩽10/>10 mg l−1) | 2.31 (1.34–3.97) | 0.003 | 3.28 (1.41–7.63) | 0.006 |
Adjuvant therapy (No/Yes) | 0.537 | 0.732 |
Values in parentheses are 95% confidence intervals.
Cox proportional hazard model.